Loading…
Dhampur Bio Organics (DBOL)₹138.12+3.12%Sugar
In the Jun 2026 quarter (consolidated), Dhampur Bio Organics reported sales of ₹535 Cr, up 8.3% from Jun 2025, and net profit of ₹36.86 Cr. For the year to Mar 2026, sales were ₹2,119 Cr and net profit ₹24.94 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 540 | 281 | 465 | 468 | 468 | 466 | 465 | 494 | 560 | 488 | 462 | 535 |
| Expenses | 518 | 284 | 381 | 433 | 475 | 447 | 368 | 483 | 565 | 443 | 380 | 523 |
| Operating Profit | 19.07 | −4.02 | 81.28 | 33.13 | −10.03 | 16.07 | 96.28 | 9.03 | −8.02 | 43.16 | 80.23 | 9.03 |
| OPM % | 3.6% | −1.6% | 17.9% | 7.0% | −2.1% | 3.4% | 21.0% | 1.8% | −1.4% | 9.0% | 17.0% | 1.7% |
| Other Income | 0.99 | 16.01 | 4.99 | 1.01 | 0.99 | −0.99 | 0.99 | −5.99 | 12.99 | 8.99 | 15.01 | 51.97 |
| Interest | 8.96 | 5.98 | 17.93 | 20.90 | 15.93 | 9.96 | 19.91 | 18.93 | 13.95 | 10.96 | 13.95 | 15.93 |
| Depreciation | 9.96 | 13.94 | 13.96 | 11.96 | 10.96 | 14.94 | 15.95 | 11.96 | 14.94 | 14.94 | 12.96 | 12.94 |
| Profit before tax | 0.00 | −8.03 | 54.17 | 1.01 | −35.10 | −10.03 | 61.20 | −29.11 | −23.09 | 26.09 | 69.19 | 32.09 |
| Tax % | 87.9% | −28.0% | 27.9% | 83.0% | −34.1% | −32.0% | 26.0% | −24.1% | −32.1% | 33.9% | 33.0% | −14.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.99 | 0.00 | −7.99 | 0.00 | 0.00 | 7.99 | 50.97 |
| Net Profit | 0.00 | −5.98 | 38.86 | 0.00 | −22.92 | −6.98 | 44.84 | −21.92 | −15.94 | 16.96 | 45.89 | 36.86 |
| EPS (Rs) | 0.02 | −0.86 | 5.95 | 0.03 | −3.51 | −1.04 | 6.76 | −3.32 | −2.42 | 2.56 | 6.98 | 5.53 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 1,569 | 2,418 | 1,872 | 1,868 | 2,119 | 2,044 |
| Expenses | 1,378 | 2,200 | 1,721 | 1,725 | 1,974 | 1,911 |
| Operating Profit | 184 | 206 | 140 | 135 | 133 | 124 |
| OPM % | 12.0% | 8.0% | 8.0% | 7.0% | 6.0% | 6.1% |
| Other Income | 8.01 | 10.99 | 19.99 | 1.99 | 29.01 | 88.96 |
| Interest | 29.88 | 40.84 | 44.83 | 66.70 | 62.80 | 54.79 |
| Depreciation | 30.89 | 40.87 | 48.85 | 53.82 | 58.82 | 55.78 |
| Profit before tax | 129 | 135 | 65.20 | 16.05 | 41.11 | 104 |
| Tax % | 20.9% | 17.9% | 28.9% | 6.0% | 38.0% | — |
| Exceptional items | 0.99 | 0.00 | 9.99 | −0.99 | −0.99 | 58.96 |
| Net Profit | 102 | 111 | 45.83 | 14.95 | 24.94 | 83.77 |
| EPS (Rs) | — | 16.73 | 7.01 | 2.22 | 3.80 | 12.65 |
| Dividend payout % | 0.0% | 20.9% | 36.0% | 55.9% | 39.9% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 66.10 | 66.02 | 66.09 | 66.08 | 66.08 | 66.13 |
| Reserves | 710 | 813 | 923 | 946 | 946 | 962 |
| Borrowings | 404 | 836 | 811 | 1,059 | 1,165 | 1,063 |
| Other Liabilities | 375 | 288 | 279 | 245 | 224 | 236 |
| Total Liabilities | 1,555 | 2,003 | 2,081 | 2,318 | 2,402 | 2,328 |
| Fixed Assets | 633 | 691 | 910 | 1,039 | 1,078 | 1,134 |
| CWIP | 6.98 | 77.85 | 35.88 | 12.96 | 78.82 | 0.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 |
| Other Assets | 915 | 1,234 | 1,135 | 1,265 | 1,245 | 1,190 |
| Inventories | 719 | 1,060 | 821 | 1,086 | 1,096 | 1,015 |
| Trade receivables | 107 | 108 | 154 | 87.87 | 54.92 | 63.93 |
| Cash & equivalents | 15.04 | 25.06 | 107 | 33.12 | 39.13 | 36.14 |
| Total Assets | 1,555 | 2,003 | 2,081 | 2,318 | 2,402 | 2,328 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | −246 | 368 | −101 | 130 | 220 |
| Cash from investing activity | −124 | −210 | −167 | −145 | −42.16 |
| Cash from financing activity | 392 | −77.71 | 169 | 18.95 | −177 |
| Net cash flow | 22.99 | 80.93 | −98.01 | 3.01 | 0.00 |
| Capex | 161 | 223 | 171 | 145 | 44.31 |
| Free cash flow | −389 | 158 | −245 | −14.99 | 177 |
| CFO / OP % | −122.0% | 191.0% | −60.0% | 102.0% | 164.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 24 | 22 | 16 | 10 | 10 |
| Inventory days | 341 | 163 | 288 | 288 | 231 |
| Days payable | 54 | 33 | 37 | 29 | 26 |
| Cash conversion cycle | 313 | 155 | 270 | 271 | 217 |
| Working capital days | 55 | 23 | 32 | 20 | 22 |
| ROCE % | 11.1% | 10.1% | 5.0% | 4.0% | 5.0% |
For the Jun 2026 quarter, Dhampur Bio Organics reported sales of ₹535 Cr, up 8.3% year on year and net profit of ₹36.86 Cr. The operating margin was 1.7%.
Dhampur Bio Organics' sales for the year to Mar 2026 were ₹2,119 Cr; over the last twelve months they were ₹2,044 Cr.
Net profit for the year to Mar 2026 was ₹24.94 Cr, and ₹83.77 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.65.
Dhampur Bio Organics reported borrowings of ₹1,063 Cr at Mar 2026, against cash and equivalents of ₹36.14 Cr.
Cash from operations was ₹220 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹177 Cr.